Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

Ryan Khouri, CTT Pharmaceutical Holdings CEO, buys $335 in CTTH stock

Ryan Khouri, CTT Pharmaceutical Holdings CEO, buys $335 in CTTH stock

Nu Holdings stock experienced a sharp 23.0% decline in pre-market trading on Monday following Brazil's presidential runoff results. The unexpected re-election of President Luiz Inácio Lula da Silva over Senator Flavio Bolsonaro, son of former President Jair Bolsonaro, caught many investors off guard and led to a broad selloff of Brazilian assets.

This political shock had a significant impact on U.S.-listed Brazilian shares, particularly in the banking sector, which includes Nu Holdings as a peer group. The iShares MSCI Brazil ETF and Petrobras also suffered sharp declines, indicating that the market reaction was driven by country-level risk rather than a specific company event.

Investors are closely watching how a Lula administration may affect Brazil's interest rates, fiscal policy, and currency exchange rates, all of which directly influence Nu's financial metrics. While some analysts, like Needham, view the downturn as a potential long-term buying opportunity, the stock's pre-market price of $14.57 is well above its 52-week low of $11.20, highlighting the extent of the technical damage.

With the next earnings release scheduled for November 12, 2026, there are no immediate company-specific catalysts to counterbalance the political disruption. The combination of these factors has pushed Nu Holdings to levels not seen in nearly a year, as investors reassess the risk premium associated with Brazil's largest digital bank.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at investing.com →

More in Finance & Markets

More from Tuesday 27 October →